scispace - formally typeset
A

Ashwin N. Ananthakrishnan

Researcher at Harvard University

Publications -  529
Citations -  30046

Ashwin N. Ananthakrishnan is an academic researcher from Harvard University. The author has contributed to research in topics: Inflammatory bowel disease & Ulcerative colitis. The author has an hindex of 70, co-authored 468 publications receiving 22807 citations. Previous affiliations of Ashwin N. Ananthakrishnan include Boston Children's Hospital & Indian Institute of Technology Madras.

Papers
More filters
Journal ArticleDOI

Geographical variation and incidence of inflammatory bowel disease among US women

TL;DR: In a population of US women, increasing latitude of residence was associated with a higher incidence of Crohn's disease and UC.
Journal ArticleDOI

Impact of Clostridium difficile on inflammatory bowel disease

TL;DR: Both vancomycin and metronidazole appear to be effective and treatment with oral vancomYcin is preferred in those with severe disease, including those who require hospitalization, and there is a need to prospectively examine whether CDI has long-term disease-modifying consequences inThose with underlying IBD.
Journal ArticleDOI

Review article: vitamin D and inflammatory bowel diseases

TL;DR: Vitamin D is traditionally associated with bone metabolism, but the immunological effects of vitamin D have increasingly come into focus.
Journal ArticleDOI

A low-cost paper-based synthetic biology platform for analyzing gut microbiota and host biomarkers

TL;DR: A low-cost, paper-based synthetic biology platform that allows species-specific quantification of bacterial mRNAs and clinically relevant host biomarkers and can be used to rapidly and inexpensively detect toxin mRNA in the diagnosis of Clostridium difficile infections is presented.